Truvestments Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Buy
7,833
+107
+1% +$5.21K 0.06% 244
2026
Q1
$331K Sell
7,726
-7
-0.1% -$301 0.06% 250
2025
Q4
$339K Buy
7,733
+205
+3% +$8.48K 0.06% 231
2025
Q3
$311K Buy
7,528
+7,020
+1,382% +$282K 0.06% 244
2025
Q2
$22.4K Buy
+508
New +$20.3K ﹤0.01% 515
2023
Q1
– Sell
-117
Closed -$1.88K – 774
2022
Q4
$1.88K Hold
117
– – ﹤0.01% 737
2022
Q3
$2K Hold
117
– – ﹤0.01% 550
2022
Q2
$2K Buy
+117
New +$2.41K ﹤0.01% 556
2019
Q4
– Sell
-261
Closed -$5K – 290
2019
Q3
$5K Buy
261
+104
+66% +$2.1K ﹤0.01% 571
2019
Q2
$3K Buy
+157
New +$3.29K ﹤0.01% 663

Other funds holding EXEL

Truvestments Capital's EXEL Position: Q2 2026 in Review

Truvestments Capital increased its Exelixis (EXEL) stake by 1.4% in Q2 2026, buying an estimated $5.21K and bringing the position to 7,833 shares worth $426K. The position accounts for 0.06% of the portfolio, ranked #244.

Truvestments Capital first reported a position in EXEL in Q2 2019 and has held it in 10 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Truvestments Capital held 7,833 shares of Exelixis worth $426K as of Q2 2026.
  • Truvestments Capital bought 107 Exelixis shares in Q2 2026, an estimated $5.21K.
  • Exelixis made up 0.06% of Truvestments Capital's portfolio in Q2 2026, its #244 holding.
  • Truvestments Capital first reported a position in Exelixis in Q2 2019 and has held it in 10 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.